Market Cap

Lonza Group Ltd Market Capitalization:

CHF37.73 Billion

CHF as of Jan. 1, 2025

US$41.66 Billion

business Lonza Group Ltd Company Profile

Lonza Group Ltd Main Stock Listing

SIX: LONN

Market Capitalization History of Lonza Group Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $219.88 B
Danaher $177.43 B
Siemens Healthineers AG $59.19 B
Agilent Technologies, Inc. $43.57 B
IQVIA Holdings Inc. $37.39 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Lonza Group Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2025 CHF37.73 B 47.36%
Jan. 1, 2024 CHF25.60 B -26.18%
Jan. 1, 2023 CHF34.68 B -25.92%
Jan. 1, 2022 CHF46.82 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Lonza Group Ltd Categories

Switzerland languages Healthcare languages Diagnostics & Research
Switzerland Healthcare Switzerland Diagnostics & Research

Stocks & Indices

Lonza Group Ltd has the following listings and related stock indices.


Stock: SIX: LONN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.